Fund detail
HHLR Advisors / Hillhouse (Zhang Lei)
china, growth, hillhouse, active
Quarters
30
2023-09-30
$4.48B
Positions
60
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RAYZEBIO INC | $31.0M | 0.69% | 1,395,716 | +1,395,716 | 2023-09-30 | $22 | ~$22 | +0.00% | |||
| 2 | NEUMORA THERAPEUTICS INC. NMRA | $24.0M | 0.54% | 1,699,313 | +1,699,313 | 2023-09-30 | $14 | ~$14 | +0.00% | |||
| 3 | SAGIMET BIOSCIENCES INC SGMT | $12.8M | 0.28% | 1,449,543 | +1,449,543 | 2023-09-30 | $9 | ~$9 | +0.00% | |||
| 4 | SEA LTD SE | $7.7M | 0.17% | 174,800 | +174,800 | 2019-03-31 | $44 | ~$138 | -68.08% | |||
| 5 | PACIFIC BIOSCIENCES CALIF IN PACB | $7.7M | 0.17% | 918,892 | +918,892 | 2021-09-30 | $8 | ~$25 | -67.22% | |||
| 6 | TESLA INC TSLA | $7.5M | 0.17% | 30,000 | +30,000 | 2019-06-30 | $250 | ~$15 | +1579.63% | |||
| 7 | AMBRX BIOPHARMA INC | $365K | 0.01% | 31,735 | +31,735 | 2023-09-30 | $12 | ~$12 | +0.00% |